Product Specification

Efficient CSTR Process and Anaerobic Solutions for Pharmaceutical Wastewater Treatment Projects in Indonesia

Indonesia has emerged as one of the fastest-growing pharmaceutical markets in Southeast Asia, driven by a large population and increasing healthcare accessibility through the JKN (National Health Insurance) program. With the government’s focus on increasing domestic production of raw materials (API) to reduce import reliance, the country’s manufacturing landscape is expanding rapidly. However, this growth brings significant environmental challenges. Managing the complex effluent from pharmaceutical process synthesis and formulation is now a critical priority for local manufacturers. As a premier global EPC contractor, Center Enamel provides high-efficiency Anaerobic Solutions, specifically the CSTR process, to help Indonesian pharmaceutical enterprises achieve sustainable operational excellence.

The Landscape of Indonesia’s Pharmaceutical Industry and Policy

Indonesia's pharmaceutical sector is characterized by a strong presence of state-owned enterprises (BUMN) and a growing number of private and multinational players. To support sustainable development, the Indonesian Ministry of Environment and Forestry (KLHK) enforces strict industrial wastewater discharge standards, such as those outlined in Regulation No. P.68/2016.

For pharmaceutical plants located in industrial hubs like Cikarang or Karawang, meeting Chemical Oxygen Demand (COD) and Biological Oxygen Demand (BOD) limits is mandatory to avoid heavy legal penalties. Advanced Pharmaceutical Wastewater Treatment Projects are now a core investment for companies looking to maintain their "PROPER" environmental rating and ensure long-term business viability in the Indonesian market.

Challenges of Pharmaceutical Wastewater in Indonesia

Pharmaceutical manufacturing generates wastewater that is far more difficult to treat than standard municipal sewage. While municipal waste originates from domestic activities like kitchens and bathrooms, industrial manufacturing effluent is defined by its chemical complexity:

High Toxicity: Residual active pharmaceutical ingredients (APIs) and solvents can inhibit the biological activity of traditional treatment systems.

High Organic Loading: Production processes often result in exceptionally high COD and BOD levels, necessitating powerful anaerobic digestion before aerobic treatment.

Fluctuating Characteristics: Frequent changes in production cycles lead to inconsistent wastewater quality, which can shock and destabilize conventional treatment plants.

Comprehensive Pharmaceutical Wastewater Treatment Flow

To handle these industrial challenges, Center Enamel delivers a high-performance treatment flow:

Pre-treatment: Physical screening and pH adjustment to stabilize the effluent for biological processes.

Anaerobic Core: The most vital stage, where reactors like CSTR or IC break down high-strength organic matter into biogas.

Aerobic Polishing: Removing residual organic pollutants and nutrients through oxidation.

Advanced Filtration: Utilizing membranes or activated carbon to ensure the water meets Indonesia's strict discharge standards for safe release or reuse.

Core Anaerobic Technologies: CSTR, IC, UASB, and USR

Center Enamel integrates a variety of specialized anaerobic processes tailored to the specific effluent profile of each plant:

CSTR (Continuous Stirred Tank Reactor): Particularly effective for pharmaceutical wastewater with high suspended solids (SS). It utilizes mechanical stirring to ensure uniform contact between microorganisms and waste, providing high stability and efficiency.

IC (Internal Circulation) Reactor: A next-generation high-rate reactor that uses a two-stage process. It circulates sludge internally, allowing it to handle massive organic loads and resist shock loads.

UASB (Upflow Anaerobic Sludge Blanket): A classic solution that passes liquid-phase sewage through a dense blanket of anaerobic sludge in a compact footprint.

USR (Upflow Solids Reactor): Specifically designed for streams with very high solid content, ensuring complete digestion of organic particles.

The Advantage of Glass-Fused-to-Steel (GFS) Tanks

Center Enamel’s EPC solutions utilize proprietary Glass-Fused-to-Steel (GFS) tanks as the primary containment vessels. These tanks offer distinct advantages over concrete in Indonesia’s tropical environment:

Superior Corrosion Resistance: The glass-to-steel bond is impervious to the aggressive chemicals and organic acids found in pharmaceutical waste.

Rapid Modular Installation: Bolted construction is significantly faster than traditional concrete pouring, reducing project timelines and minimizing downtime for manufacturing facilities.

Flexibility and Durability: Designed for a service life of over 30 years, these tanks can be easily expanded or relocated as production capacity grows.

Why Choose Center Enamel as Your EPC Contractor?

As a premier global EPC contractor, Center Enamel provides a seamless, turnkey experience:

Customized Engineering: Precision-designed systems tailored to the specific chemical footprint of the pharmaceutical facility.

International Expertise: With projects in over 100 countries, we bring world-class standards to the Indonesian market.

Full Lifecycle Support: From initial process design and GFS tank fabrication to automated control systems and long-term commissioning.

Success Stories in Pharmaceutical Treatment

Case1: Inner Mongolia Pharmaceutical Wastewater Treatment Project

Process: UASB

Tank Dimensions: φ13.76 × 13.2 m (H) — 1 Unit

Total Tank Volume: 1,962 m³

Completion Date: 2023

Case2: Zhejiang Pharmaceutical Plant Wastewater Treatment Project

Process: IC

Tank Dimensions: φ12.66 × 24 m (H) — 6 Units

Total Tank Volume: 18,114 m³

Completion Date: 2019

As Indonesia’s pharmaceutical industry moves toward higher environmental standards and sustainable growth, the need for advanced wastewater solutions is critical. Center Enamel’s integration of the CSTR process and Glass-Fused-to-Steel technology provides manufacturers with a future-proof foundation for environmental compliance. By selecting a professional EPC partner with specialized anaerobic expertise, Indonesian pharmaceutical companies can effectively protect local water resources while ensuring their long-term economic competitiveness in the global market.